The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? - Wikidata - wikimedia - TriplyDB

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

http://www.wikidata.org/entity/Q34064605

about

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance Multiple receptors for HLA-G on human natural killer cells HLA-G Molecules in Autoimmune Diseases and Infections The dual role of HLA-G in cancer Controlling the Immunological Crosstalk during Conception and Pregnancy: HLA-G in Reproduction Innate immunity, decidual cells, and preeclampsia Recent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human Diseases The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis Lymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathway Tolerogenic function of dimeric forms of HLA-G recombinant proteins: a comparative study in vivo Synthetic HLA-G proteins for therapeutic use in transplantation.Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation.HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells.Impact of HLA-G in the outcome of vitiligo in Tunisian patients Membrane redistributions through multi-intercellular exchanges and serial trogocytosis.HLA-G as a tolerogenic molecule in transplantation and pregnancy.Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis.HLA-G-mediated NK cell senescence promotes vascular remodeling: implications for reproduction.HLA and pregnancy: the paradox of the fetal allograft.HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population HLA-G is found in lipid rafts and can act as a signaling molecule HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?Association of HLA-G low expressor genotype with severe acute graft-versus-host disease after sibling bone marrow transplantation.Natural killer cells fertile with receptors for HLA-G?The mother-child union: the case of missing-self and protection of the fetus HLA class I specificity for natural killer cell receptor CD94/NKG2A: two for one in more ways than one.KIR2DL4 (CD158d): An activation receptor for HLA-G.Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?HLA-G in human reproduction: aspects of genetics, function and pregnancy complications.Soluble HLA-G: Are they clinically relevant?Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11.Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.Toward eliminating HLA class I expression to generate universal cells from allogeneic donors Emerging topics and new perspectives on HLA-G.The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.HLA-G: a look back, a look forward.Nanoparticles targeting HLA-G for gene therapy in cancer.How tumors might withstand γδ T-cell attack.

P2860

Q24323589-4CB338DF-6E71-48B1-998F-90AC122C5D96 Q24645618-74D31946-5756-4F42-8A07-E8A4C931B344 Q26825516-D72D28CA-CEE7-4F67-A473-D8D33C85DD79 Q26860886-013562E3-457A-4DC1-8C7A-FD13F6D69329 Q26996465-DB2B72FA-EEF8-4769-9E64-C6F0D5194694 Q27014127-B2031F86-63F8-4F37-9922-F473D1D359E1 Q28079536-76E5B825-78F3-43E1-BC9B-649424C30015 Q28362622-E99EB4EE-5A93-4FB4-B5D0-54F06F40DD23 Q28476661-040D1F0E-F03A-45EF-B5AA-C1BEE69614CF Q28742634-ED2EFF82-3059-43A0-AADF-D4DE09543858 Q30543621-3631DA09-DCD1-4F4C-BF3A-E9A118C8FA00 Q33642419-BB7E959A-46DE-4B84-BCDC-95EFF582CC09 Q33782535-E6F22C90-1E71-4685-84D9-133C14F66720 Q33796649-3B920C1D-10A5-41E9-A01B-607826F78EBD Q34024115-AC860877-10BA-4467-A7A8-3FCA849B0D3C Q34038019-E64D9A82-3912-46A0-A867-38367B8F4E6D Q34065286-576BC387-2A8F-471D-8646-111417B2C736 Q34339809-721CBF8F-66FD-4BA9-B399-FC7EAE769B9E Q34384251-A3BE0959-FE6F-4C95-B69D-59877DD36826 Q35030797-8A04F25B-2422-4439-8236-5A0BFE7C6488 Q35034429-27A50003-6B08-4904-9FD3-336EBD28BA1C Q35728604-9B4750C4-9AA4-420D-8F6C-BC5BA74651C7 Q35746565-B6092C1C-83C9-433E-B288-7DB1BAAA9128 Q35928084-E913D14D-EC08-4793-8FD0-2CC0BEA4A127 Q35976764-4ED7C1F8-BA70-44C6-8781-E1B8DBEEBD40 Q36009126-8E1BD192-D3A1-44B7-9415-74A9763CA684 Q36064217-0E82799B-7924-4A95-9E70-BA1DCF822C6B Q36174860-FC06FF51-E922-46D7-BEDB-92A4DC75FC32 Q36179791-E55367EC-5A0D-46E6-85A3-6499E50166DC Q36184793-872C1308-5BFF-4D93-BECA-934E567DABCC Q36310336-865120A1-49DE-4766-AF76-6B1699155874 Q36384011-56BF695C-197B-4009-87E7-9AF63A5C7467 Q36401515-C064B574-2C45-4BC9-8469-13D014E12113 Q36545749-B15493E8-3688-4BF0-9577-27136080DA4D Q37113074-3FBDB4B0-39AB-4BC9-A80F-3D660E056C0B Q37809764-26E5CB10-B35D-45EA-8223-2BAF65E9A9FF Q37809765-619BE459-381E-4648-8992-54BDEE986275 Q37810814-FB17349B-1309-449E-91DA-6F23A2A59BB6 Q37866158-DDB9FCF9-82A6-43EE-ADE3-913D935F7C1D Q37872644-C27D632E-5548-45BC-8D3F-BE6FA99D57F6

P2860

The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?

http://www.wikidata.org/entity/Q34064605

description

1997 nî lūn-bûn

@nan

1997 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի մայիսին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

The alpha1 domain of HLA-G1 an ...... ler cell inhibitory receptors?

@ast

The alpha1 domain of HLA-G1 an ...... ler cell inhibitory receptors?

@en

The alpha1 domain of HLA-G1 an ...... ler cell inhibitory receptors?

@nl

type

label

The alpha1 domain of HLA-G1 an ...... ler cell inhibitory receptors?

@ast

The alpha1 domain of HLA-G1 an ...... ler cell inhibitory receptors?

@en

The alpha1 domain of HLA-G1 an ...... ler cell inhibitory receptors?

@nl

prefLabel

The alpha1 domain of HLA-G1 an ...... ler cell inhibitory receptors?

@ast

The alpha1 domain of HLA-G1 an ...... ler cell inhibitory receptors?

@en

The alpha1 domain of HLA-G1 an ...... ler cell inhibitory receptors?

@nl

P1433

Q34064605-857D4E50-C86B-4BC2-AD9F-434467F16F5F

P1476

Q34064605-CFAE8DF7-DADE-4B23-B8E7-EAAAFDEBF0D5

P2093

Q34064605-1B291E62-6B29-4A55-B508-D1F239B03D76

Q34064605-73097E60-A95F-4F3B-AA1F-EE01DF7FC2D3

Q34064605-8784794E-0C8C-4EED-996C-86186E74612F

Q34064605-95C3A39E-8416-4EDB-9A71-E9EE96C0FDF7

P2860

Q34064605-02B48197-B382-44F1-8F3E-544FC4253AE8

Q34064605-068F8C64-2CF1-45D7-B79C-FBD7E238D381

Q34064605-210C3493-8F17-4D97-8068-E2DF321E71E8

Q34064605-27A87218-C17F-412A-BE2C-4B8FC4FFA6A3

Q34064605-281DAD0A-813D-4F4B-95F0-2C99FB4C27DC

Q34064605-2A6D168A-A813-4235-B35E-421E8FEAD511

Q34064605-4A31490C-5766-4F25-BCC1-8562E518C9EA

Q34064605-4B46CC68-1E13-4F29-8816-F3EC52C2FC1E

Q34064605-4DA82A34-1F20-49E0-BB1B-ED9DDE7E83E6

Q34064605-564AF8B1-679B-4E61-A05B-5C9AB748F2EB

P304

Q34064605-7F83637F-75AC-46D6-9C66-EFE717CC2666

P31

Q34064605-B5317508-9822-4D40-B0EB-1762DD184620

P356

Q34064605-FFF7DCDC-4055-4B06-B743-7BBDC7583008

P407

Q34064605-CF8F1B08-4B56-435E-9A31-473DA2D0BD4B

P433

Q34064605-260DDE7A-C29F-445A-B021-A422E6B22B0C

P478

Q34064605-913D26A5-69B4-4A6B-91B3-1D607445F658

P50

Q34064605-AE62F9AA-BF9E-4403-A5EA-9A048B6D6A52

P577

Q34064605-E2418AFD-99D3-4746-ADD4-52CC27FC0AEE

P5875

Q34064605-63C734CA-32C3-4E8C-A45C-450D367CE373

P698

Q34064605-FBC2BF10-7474-4217-9856-B265222D68DE

P921

Q34064605-5E424D99-1CF1-4251-87E7-F99FAC3ABA69

P932

Q34064605-F7A1D77F-B563-4F6C-96E2-05AEF9CC2243

P356

PNAS.94.10.5249

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

The alpha1 domain of HLA-G1 an ...... ler cell inhibitory receptors?

@en

P2093

E D Carosella

http://www.w3.org/2001/XMLSchema#string

M Kirszenbaum

http://www.w3.org/2001/XMLSchema#string

N Rouas-Freiss

http://www.w3.org/2001/XMLSchema#string

R E Marchal

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells

Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles

CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes

An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes.

Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule.

Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules.

HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells

Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene

Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens.

HLA-G gene polymorphism segregation within CEPH reference families.

P304

5249-5254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.94.10.5249

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

P577

1997-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14074673

http://www.w3.org/2001/XMLSchema#string

P698

9144223

http://www.w3.org/2001/XMLSchema#string

P921

P932

24664

http://www.w3.org/2001/XMLSchema#string